INS and diabetes mellitus: In this nationally representative cohort study using Medicare 2016 to 2020 data, CGM use was associated with a lower risk of all-cause hospitalization and mortality compared with prevalent SMBG users in insulin-treated older adults with diabetes and ADRD.